Amprius Technologies (NYSE:AMPX – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.01), FiscalAI reports. The business had revenue of $39.15 million during the quarter, compared to analysts’ expectations of $35.80 million. Amprius Technologies had a negative return on equity of 12.01% and a negative net margin of 29.94%. During the same quarter in the prior year, the firm earned ($0.03) EPS.
Amprius Technologies Trading Down 6.6%
Shares of AMPX opened at $8.56 on Thursday. The firm has a market cap of $1.21 billion, a PE ratio of -30.57 and a beta of 2.36. The firm has a fifty day simple moving average of $9.06 and a two-hundred day simple moving average of $13.21. Amprius Technologies has a 1-year low of $7.02 and a 1-year high of $24.23.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on AMPX shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Amprius Technologies in a research report on Thursday, October 15th. Canaccord Genuity Group started coverage on Amprius Technologies in a research report on Wednesday, October 14th. They issued a “buy” rating and a $14.00 target price for the company. UBS Group restated an “outperform” rating on shares of Amprius Technologies in a research note on Friday, November 6th. Needham & Company LLC dropped their price target on shares of Amprius Technologies from $20.00 to $15.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, National Bank Financial set a $18.00 price target on shares of Amprius Technologies in a report on Tuesday, September 29th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $21.00.
View Our Latest Analysis on Amprius Technologies
Insider Activity
In related news, CTO Constantin Stefan sold 29,681 shares of Amprius Technologies stock in a transaction on Friday, August 21st. The stock was sold at an average price of $10.34, for a total value of $306,901.54. Following the completion of the sale, the chief technology officer owned 771,629 shares of the company’s stock, valued at $7,978,643.86. The trade was a 3.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Thomas M. Stepien sold 23,529 shares of the company’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $10.34, for a total value of $243,289.86. Following the sale, the chief executive officer owned 602,096 shares of the company’s stock, valued at approximately $6,225,672.64. This trade represents a 3.76% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 123,311 shares of company stock valued at $1,272,556 in the last ninety days. 5.10% of the stock is currently owned by company insiders.
Key Stories Impacting Amprius Technologies
These are some of the AMPX stories that stood out recently:
- Positive Sentiment: The company plans to build U.S. pouch-cell capacity capable of producing 12 million cells annually by early 2028, which could support its growth ambitions if demand and execution materialize. Capacity and revenue outlook
- Neutral Sentiment: Needham lowered its price target from $20 to $15 but maintained a Buy rating. The reduced target reflects a less optimistic valuation, while the firm still sees potential upside from the cited $8.56 reference price. Needham analyst ratings
- Negative Sentiment: Quarterly EPS was a loss of $0.02, missing the $0.01-per-share loss analysts expected. Freight costs weighed on margins, and the earnings shortfall appears to have outweighed the revenue beat in the market’s reaction. Q3 earnings call transcript
Amprius Technologies Company Profile
Amprius Technologies, Inc. develops and manufactures lithium-ion batteries designed to provide high energy density and power. Its battery technology uses silicon-based anodes, an alternative to the graphite anodes commonly used in conventional lithium-ion cells. The company’s products are designed for applications where low weight and high performance are important, including electric aviation, drones, aerospace, defense and other mobility markets. Amprius offers silicon-anode cells for customers developing these systems.
Read More
- Five stocks we like better than Amprius Technologies
- The Post-Midterm Rally Clock Is Ticking—and These 3 AI Stocks Stand Out
- Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-Off
- Palantir’s Real Washington Risk Isn’t the Budget—It’s Oversight
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
